Jishan Quan

Dr. Jishan Quan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ZGZhen Guo
Zhen Guo
XSXiaowei Song
Xiaowei Song
LZLi-Min Zhao
Li-Min Zhao
MPMing Guan Piao
Ming Guan Piao
JQJishan Quan
Jishan Quan
CJCheng-Hua Jin
Cheng-Hua Jin

13 March 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YMYu-Qing Meng
Yu-Qing Meng
JRJie Ren
Jie Ren
JSJing-Xin Sun
Jing-Xin Sun
FGFang-Yan Guo
Fang-Yan Guo
JMJun-Zhe Min
Jun-Zhe Min
CJCheng-Hua Jin
Cheng-Hua Jin

25 December 2018 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
XSXiaowei Song
Xiaowei Song
GYGuanghai Yan
Guanghai Yan
SQSongshi Quan
Songshi Quan
EJEnhao Jin
Enhao Jin
JQJishan Quan
Jishan Quan
GJGuangyu Jin
Guangyu Jin
To noninvasively monitor the effect of gene therapy and achieve an optimal therapeutic effect, liposomes encapsulated polyethylenimine (PEI)-coated superparamagnetic iron oxide nanoparticles (SPION) with dual functions of MRI diagnosis and gene therapy were prepared. SPION was synthesized via co-precipitation, and then modified with PEI via thiourea reaction. The liposomes encapsulating PEI-SPION (LP-PEI-SPION) were prepared by ethanol injection. Fourier transform infrared spectra confirmed that PEI was successfully modified onto SPION, and thermogravimetric analysis indicated that the PEI content was about 17.1%. The LP-PEI-SPION/DNA had a small particle size of 253.07 ± 0.90 nm. LP-PEI-SPION/DNA had low cytotoxicity with more than 80% of the cell survival rates and high transfection efficiency compared with Lipofectamine® 2000/DNA. Additionally, it also showed good MRI effect on three cell lines. The liposomes encapsulating PEI-SPION (lipopolyplexes) have been successfully prepared as MRI contrast agents and gene delivery vectors, which may have great theoretical research significance and clinical potentials.Abbreviations: PEI, polyethylenimine; SPION, superparamagnetic iron oxide nanoparticles; LP-PEI-SPION, liposomes encapsulating PEI-SPION; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; ICP-MS, inductively coupled plasma mass spectrometry; XRD, X-ray diffraction; TEM, transmission electron microscope; TGA, thermogravimetric analysis; DOTAP, 1,2-dioleoyl-3-trimethylammonium-propane; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; Chol, cholesterol.

1 January 2021
Verified
Journal Article
Open access
JSJingxin Sun
Jingxin Sun
YZYuanfei Zhou
Yuanfei Zhou
GJGuangyu Jin
Guangyu Jin
YJYong Jin
Yong Jin
JQJishan Quan
Jishan Quan
In order to improve the transfection efficiency of gene vectors and monitor the effect of gene therapy, this study prepared a drug delivery vector with dual functions. The thiourea reaction was used to synthesize polyethyleneimine (PEI, MW: 1.8 kDa) with superparamagnetic iron oxide nanoparticles (SPION) (PEI1800-SPION), and the lipid polycationic gene vector PEI1800SPION loaded cationic liposome (LP-PEI1800-SPION) was further prepared by ethanol injection method. Agarose gel electrophoresis experiment, cytotoxicity experiment, and In-vitro gene silencing experiment were used to evaluate the vector and screen the optimal prescription of LP-PEI1800-SPION/siRNA. When the weight ratio of LP-PEI1800-SPION to siRNA is 20, the transfection efficiency of the nanoparticles was the highest, and the silencing efficiency of the target protein was the largest. The cytotoxicity of LP-PEI1800-SPION was low; when the concentration was in the range of 1-50 mu g/mL, the survival rate of the four types of cells was above 80%. Prussian blue staining experiments and In-vitro MRI imaging experiments showed that cells had significant uptake and imaging capabilities for LP-PEI1800-SPION. In conclusion, the visualized polycationic lipid siRNA delivery vehicle (LP-PEI1800-SPION) was successfully prepared in this experiment, which provides a research basis for further theranostics of liver cancer.

6 August 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
YLYue Li
Yue Li
TYTing Yu
Ting Yu
LHLong-Zhe Han
Long-Zhe Han
LJLi-Li Jin
Li-Li Jin
YJYong Jin
Yong Jin
JQJishan Quan
Jishan Quan

1 January 2020 in Indian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
YCY. Q. Cui
Y. Q. Cui
PYP. Yang
P. Yang
PSP. Sun
P. Sun
YYY.D. Yan
Y.D. Yan
GJG.Y. Jin
G.Y. Jin
JQJishan Quan
Jishan Quan
In this study, ginsenoside Rg3-loaded PEGylated liposomes were prepared and optimized using the Box- Behnken design. These liposomes were characterized, the cumulative release profiles were investigated and compared with ginsenoside Rg3-loaded liposomes in vitro. To improve the stability ginsenoside Rg3-loaded PEGylated liposomes were freeze-dried and the lyoprotectants to be added were screened. The results showed that the liposomes have a small particle size (152.58±0.74 nm) and spherical shape. The encapsulation efficiency and drug-loading rate were approximately 85.24±1.02 and 7.44±0.08 %, respectively. For lyoprotectants, 2 % lactose was chosen as the lyophilized protectant according to the appearance, re-dispersity, particle size, and entrapment efficiency of lyophilization of ginsenoside Rg3- loaded PEGylated liposomes. In vitro release showed that ginsenoside Rg3-loaded PEGylated liposomes showed a more obvious sustained release effect, which suggests that ginsenoside Rg3-loaded PEGylated liposomes might enhance the therapeutic effect of ginsenoside Rg3.